We are live on ! Find out more
TG

TRV GP Portfolio holdings

AUM $18.9M
1-Year Est. Return 541.67%
This Fund
S&P 500
This Quarter Est. Return
-1.88%
1 Year Est. Return
+541.67%
3 Year Est. Return
+3,178.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$45.6M
AUM Growth
-$5.33M
Cap. Flow
-$4.78M
Cap. Flow %
-10.48%
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

1
CNST
Constellation Pharmaceuticals, Inc.
CNST
+$4.78M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNST
1
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$42.1M 92.36%
1,401,422
-132,661
-9% -$4.78M
CARM
2
DELISTED
Carisma Therapeutics
CARM
$3.49M 7.64%
242,080
– –

Similar funds

KA
KSL Advisors Denver, Colorado $16.1M AUM
FRGX
First Reserve GP XII Stamford, Connecticut $3.16M AUM 24.66% 1-Year Est. Return
DHRFI
DCM Hybrid RMB Fund International Menlo Park, California $35.3M AUM
SA
Silversage Advisors Irvine, California $2.41M AUM 46.55% 1-Year Est. Return
YECIP
YT Extraction Co Investment Partners New York $1.73M AUM
FFIM
Founders Fund II Management San Francisco, California $1.32M AUM
ES
Equitec Specialists Chicago, Illinois $708K AUM 25.27% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM

TRV GP's Q2 2020 Portfolio in Review

As of Q2 2020, TRV GP held 2 positions worth $45.6M, down 10% from $50.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

TRV GP withdrew a net $4.78M in Q2 2020, reducing 1 holding. Its largest reduction was Constellation Pharmaceuticals, Inc., cutting an estimated $4.78M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • TRV GP's biggest Q2 2020 reduction was Constellation Pharmaceuticals, Inc., cutting an estimated $4.78M.
  • TRV GP's ten largest holdings make up 100% of its $45.6M portfolio in Q2 2020.
  • TRV GP opened 0 new positions and closed 0 in Q2 2020.
  • TRV GP's portfolio value fell 10% quarter-over-quarter to $45.6M.

Based on TRV GP's 13F filing for Q2 2020, filed 7 Aug 2020.